Review of important clinical advances in diabetes
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.1000-6699.2012.04.005
   		
        
        	
        		- VernacularTitle:糖尿病重要临床进展回顾
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Qingguo Lü
			        		
			        		;
		        		
		        		
		        		
			        		Nanwei TONG
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Diabetes mellitus;
			        		
			        		
			        		
				        		Clinical advance;
			        		
			        		
			        		
				        		Guideline;
			        		
			        		
			        		
				        		Consensus;
			        		
			        		
			        		
				        		Drug safety
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Endocrinology and Metabolism
	            		
	            		 2012;28(4):271-275
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	During the past year of 2011,International Diabetes Federation ( IDF),American Association of Clinical Endocrinologists ( AACE),Chinese Diabetes Society,and Chinese Society of Endocrinology,etc had published some guidelines and consensuses on clinical diagnosis,treatment,laboratory test,and complication therapy of diabetes.Characters of diabetic angiopathy in Chinese and death cause of diabetes were also announced by several new studies.Meanwhile,Food and Drug Administration ( FDA ) and The European Agency for the Evaluation of Medicinal Products(EMEA) declared their statements on safety of several hypoglycemic agents.These guidelines and consensuses will play key roles on standard clinical diagnosis,treatment,and medication.